Skip to content

AcrySof™ IQ Vivity™ DFT015 (REF DFT015.265)Recalls & reported problems

Alcon Laboratories, Inc. · Sterile UV and Blue Light Filtering Acrylic Foldable Aspheric Wavefront-Shaping Posterior Chamber Intraocular Lens · Class 3 · Implant

All models of AcrySof IQ Vivity (225)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380652421362), received between May 7, 2023 and May 7, 2023 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Blurred Vision1
  • Visual Disturbances1
  • Visual Impairment1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 7, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A NON-HEALTHCARE PROFESSIONAL REPORTED THAT AFTER BILATERAL IMPLANTATION OF INTRAOCULAR LENS (IOL), THE PATIENT HAD TROUBLE WITH GLARE AT NIGHT DRIVING, LETTERS WERE SLOPPY AND PATIENT SEE WELL UP CLOSE BUT SEE POORLY IN THE DISTANCE. THE PATIENT WAS PRESCRIBED WITH CORTICOSTEROID DROPS, A LOT OF TEARS DROPS. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS PATIENT. THIS IS 2 OF 2.

    Patient problems: Blurred Vision; Visual Disturbances; Visual Impairment

    MAUDE report 16883716 ↗

Other Extended depth of focus intraocular lens devices

All Extended depth of focus intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page